SCHEDULE: Deep Track Capital Discloses Geron Corp Stake

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 4.95% of Geron Corp's common stock as of March 31, 2026.

Summary

• Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have jointly filed a Schedule 13G, indicating their beneficial ownership of Geron Corp's common stock.
• As of March 31, 2026, the reporting persons collectively beneficially owned 31,720,278 shares of Geron Corp's common stock.
• This ownership represents 4.95% of the class of securities outstanding.
• The filing specifies that Deep Track Capital, LP is the entity for which David Kroin may be considered a control person.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance updates.

Positives

• The reporting persons hold a significant stake, representing 4.95% of Geron Corp's common stock, indicating substantial investment interest.
• The filing is up-to-date as of March 31, 2026, providing current ownership information.

Future Outlook

This filing does not contain forward-looking statements or guidance from the company. It solely reports on beneficial ownership.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors or other entities that acquire beneficial ownership of more than 5% of a company's voting stock. This filing indicates a significant investment position by Deep Track Capital in Geron Corp, a biotechnology company.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant ownership stakes, which can influence market perception and trading activity.

Key Dates

Keywords

Geron Corp, Schedule 13G, Deep Track Capital, Beneficial Ownership, Common Stock, SEC Filing, Investment